Stay updated on Clinical Trial of Amcenestrant in Japanese Breast Cancer
Sign up to get notified when there's something new on the Clinical Trial of Amcenestrant in Japanese Breast Cancer page.

Latest updates to the Clinical Trial of Amcenestrant in Japanese Breast Cancer page
- Check3 days agoChange DetectedThe clinical trial record for the AMEERA-2 study is now displayed, with details about its design, participants, locations, and outcomes. It indicates the study was terminated by sponsor decision, not due to a safety concern.SummaryDifference45%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe displayed ClinicalTrials.gov site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the NCT03816839 study record is blocked by a 403 Forbidden page, replacing the original study details with a standard error message. The header and footer remain, but the core study content is inaccessible.SummaryDifference18%

Stay in the know with updates to Clinical Trial of Amcenestrant in Japanese Breast Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of Amcenestrant in Japanese Breast Cancer page.